We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form

By LabMedica International staff writers
Posted on 02 Oct 2023
Print article
Image: A new test could detect the body’s adaptive immune response to viruses (Photo courtesy of 123RF)
Image: A new test could detect the body’s adaptive immune response to viruses (Photo courtesy of 123RF)

The adaptive immune system is an incredible defense mechanism that allows the human body to identify and mount targeted responses against specific pathogens. T-Cells, a special kind of white blood cell, are crucial for directing these immune reactions. These cells have specialized structures called T-Cell receptors that enable them to spot and bind to antigens on infected or abnormal cells. Evaluating T-Cells could offer a more precise understanding of immunity because the immune response from T-Cells generally endures longer than that from antibodies. Now, a new test intended to detect the body’s adaptive immune response to viruses can help respond to future viral threats.

Virax Biolabs (London, UK) is developing the ViraxImmune test, which is designed to measure T-Cell activation when a blood sample encounters a set of proteins simulating viral exposure in the body. Unlike antibodies, T-Cells serve as coordinators of the immune system's fight against viral invasion. Detecting these cells could provide insights into natural resistance against diseases for those who haven't been infected and could also help gauge the level of long-term immunity that someone has after recovering from a viral infection. The ViraxImmune test aims to identify T-Cells that remain in the body long after the initial immune response from antibodies, due to vaccination or infection, has faded. This is expected to offer a more accurate view of long-term immunity compared to just measuring antibody levels.

The ViraxImmune test has additional capabilities. It can identify if someone had been previously exposed to a virus even when initial antibody responses have faded or vanished. It's also possible that someone could have some level of immunity to a virus without ever having been exposed to it. For healthcare providers, the test serves as a sophisticated diagnostic tool that can detect early immune responses, sometimes even before antibodies have a chance to develop. This can enable healthcare providers to make decisions that are tailored to each patient's specific immune characteristics. For individuals being tested, this opens up the possibility of earlier interventions, more closely monitored conditions, and treatment plans that are customized to their needs. The test is structured to fit smoothly into current healthcare workflows, delivering timely and accurate results.

Related Links:
Virax Biolabs 

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Flu Test
Influenza A/B Virus Detection Kit
New
Gold Member
Human Chorionic Gonadotropin Test
b-hCG Cassette

Print article

Channels

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.